Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
The effect of stress on efficacy of dendritic cell therapy for esophageal squamous cell carcinoma.
/in Dendritic Cells, Hyperthermia, International Publications /von Yasunori Akutsu, Wei Qin, Kentaro Murakami, Isamu Hoshino, Naoyuki Hanari, Takanori Nishimori, Mikito Mori, Yuka Isozaki, Takeshi Toyozumi, Xin Hu, HIroshi Suito, Naoki Akanuma, Masahiko Takahashi, Hisahiro Matsubara; University of Chiba, Chiba, Japan; Chiba University, Chiba, JapanResponse of blood flow to hyperthermia in human prostate tumors: Opportunities for enhanced radiation effect and drug delivery.
/in Hyperthermia, International Publications, Prostate Cancer /von Mark Hurwitz, Gregory T Martin, Daniel A Sidney, Charles J Welch, Jorgen L Hansen, Bruce A Bornstein, Irving D. Kaplan, H F Bowman; Department of Radiation Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA; MIT, Cambridge, MA; Hemedex, Cambridge, MA; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA; Beth Israel Deaconess Medical Center, Boston, MAAntigen-specific immunity and tumor inflammation after vaccination with BPX-101, a drug-activated dendritic cell vaccine for metastatic castration-resistant prostate cancer (mCRPC).
/in Dendritic Cells, International Publications, Prostate Cancer /von T. M. Wheeler, B. Zhao, G. Sonpavde, J. D. McMannis, Y. Bai, N. Lapteva, M. Seethammagari, J. M. Levitt, D. M. Spencer, K. M. Slawin; Department of Pathology, Baylor College of Medicine, Houston, TX; University of Texas Health Science Center at Houston, Houston, TX; Texas Oncology, Baylor College of Medicine, Houston, TX; University of Texas M. D. Anderson Cancer Center, Houston, TX; Memorial Hermann Hospital-Texas Medical Center, Houston, TX; Baylor College of Medicine, Houston, TX; Vanguard Urologic Institute, Houston, TXA phase I, open label, dose escalation and cohort expansion study to evaluate the safety and immune response to autologous dendritic cells (DC) transduced with AdGMCA9 (DC-AdGMCAIX) in patients with mRCC.
/in Dendritic Cells, Hypernephroma, International Publications /von Fairooz F. Kabbinavar, Nazy Zomorodian, Arie S. Belldegrun, Steven G. Wong, Adrian Bot, Thinle Chodon, Begonya Comin-Anduix, Phuong Nguyen, Faraz Khan, Matthew Rettig, Allan J. Pantuck; Institute of Urologic Oncology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA; University of California, Los Angeles, Los Angeles, CA; Kite Pharma, Los Angeles, CA; Roswell Park Cancer Institute, Buffalo, NY; University of California, Los Angeles David Geffen School of Medicine, Los Angeles, CA; UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CACan Dendritic Cell Vaccination Prevent Leukemia Relapse?
/in Acute Leukemia, Dendritic Cells, International Publications /von O'Brien LJ, Guillerey C, Radford KJDendritic cell/cytokine-induced killer cell-based immunotherapy in lung cancer: What we know and future landscape
/in Dendritic Cells, International Publications, NSCLC /von Mohsenzadegan M, Peng RW, Roudi RPredicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1
/in Dendritic Cells, International Publications, Pancreatic Cancer /von Ito Z, Kan S, Bito T, Horiuchi S, Akasu T, Yoshida S, Kajihara M, Hokari A, Saruta M, Yoshida N, Kobayashi M, Ohkusa T, Shimodaira S, Okamoto M, Sugiyama H, Koido SThe effect of modulated electro-hyperthermia on local disease control in HIV-positive and -negative cervical cancer women in South Africa: Early results from a phase III randomised controlled trial
/in Cervical Cancer, Hyperthermia, International Publications /von Minnaar CA, Kotzen JA, Ayeni OA, Naidoo T, Tunmer M, Sharma V, Vangu MD, Baeyens ASafety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma.
/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von Katherine B. Peters, Gerald E. Archer, Pamela Norberg, Weihua Xie, Stevie Threatt, Eric S Lipp, James Emmett Herndon, Patrick Healy, Kendra Congdon, Luis Sanchez-Perez, Henry S. Friedman, Annick Desjardins, Gordana Vlahovic, John H. Sampson; Duke University Medical Center, Durham, NCModulated electro-hyperthermia induced p53 driven apoptosis and cell cycle arrest additively support doxorubicin chemotherapy of colorectal cancer in vitro
/in Colorectal Cancer, Hyperthermia, International Publications /von Vancsik T, Forika G, Balogh A, Kiss E, Krenacs TPhase I/II Pilot Study of Wilms‘ Tumor 1 Peptide-Pulsed Dendritic Cell Vaccination Combined With Conventional Chemotherapy in Patients With Head and Neck Cancer
/in Dendritic Cells, International Publications /von Ogasawara M, Miyashita M, Yamagishi Y, Ota SClinical efficacy of vaccination with the autologous tumor lysate particle loaded dendritic cell (TLPLDC) vaccine in metastatic melanoma.
/in Dendritic Cells, International Publications, Malignant Melanoma /von Annelies Hickerson, Guy T. Clifton, Tommy A Brown, Jessica Campf, John William Myers, Timothy J. Vreeland, Diane F. Hale, Kaitlin M. Peace, Doreen O Jackson, Xianzhong Yu, Thomas Wagner, George Earl Peoples; Brooke Army Medical Center, Fort Sam Houston, TX; Department of Surgery, Brooke Army Medical Center, Fort Sam Houston, TX; San Antonio Military Medical Center, San Antonio, TX; San Antonio Military Medical Center, Fort Sam Houston, TX; University of Texas MD Anderson Cancer Center, Houston, TX; Clemson University, Clemson, SC; Perseus PCI, Greenville, SC; Cancer Vaccine Development Program, San Antonio, TXDendritic cell vaccination in metastatic uveal melanoma as compassionate treatment: Immunological and clinical responses.
/in Dendritic Cells, International Publications, Malignant Melanoma /von Alvaro Moreira, Stefanie Gross, Ugur Uslu, Jan Doerrie, Mirko Kummer, Stefan Schliep, Felix Sponagl, Christopher Lischer, Michael Erdmann, Lucie Heinzerling, Gerold Schuler, Beatrice Schuler-Thurner; Department of Dermatology, University Hospital Erlangen, Erlangen, Germany; Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Germany, Erlangen, GermanyA phase II open labeled, randomized study of poly-ICLC matured dendritic cells for NY-ESO-1 and Mean-A peptide vaccination compared to Montanide, in melanoma patients in complete clinical remission.
/in Dendritic Cells, International Publications, Malignant Melanoma /von Anna C. Pavlick, Ana Blazquez, Marcia Meseck, Michael J. Donovan, Mireia Castillo-Martin, Tin Htwe Thin, Rachel Sabado, John P. Mandeli, Sacha Gnjatic, Philip Adam Friedlander, Nina Bhardwaj; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY; Icahn School of Medicine at Mount Sinai, New York, NY; Mount Sinai Medical Center, New York, NY; Genentech, Inc., San Francisco, CA; Mount Sinai School of Medicine, New York, NY; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NYDendritic-cell vaccine (DCVAC) with first-line chemotherapy in patients with stage IV NSCLC: Final analysis of phase II, open label, randomized, multicenter trial.
/in Dendritic Cells, NSCLC /von Libor Havel, Vitezslav Kolek, Milos Pesek, Markéta Cernovská, Jirina Bartunkova, Radek Spisek, Ladislav Pecen, Inna Krasnopolskaya, Milada Zemanova, SLU01 Investigators; Thomayer's Hospital, 1st Faculty of Medicine of Charles University in Prague, Prague, Czech Republic; University Hospital Olomouc, Olomouc, Czech Republic; Department of Pneumooncology, University Hospital in Pilsen, Plzen, Czech Republic; Thomayer Hospital, Prague, Czech Republic; University Hospital Motol, Prague, Czech Republic; SOTIO a.s., Prague, Czech Republic; First Faculty of Medicine, Charles University in Prague, Prague, Czech RepublicPreliminary results of a phase I clinical trial using an autologous dendritic cell cancer vaccine targeting HER2 in patients with metastatic cancer or operated high-risk bladder cancer (NCT01730118).
/in Dendritic Cells, Urothelial Carcinoma /von Hoyoung M. Maeng, Lauren Virginia Wood, Brittni Moore, Mohammadhadi H. Bagheri, Santhana Webb, Lee England, Giselle Martinez, Seth M. Steinberg, Svetlana Pack, David Stroncek, John Charles Morris, Masaki Terabe, Jay A. Berzofsky; National Cancer Institute, Bethesda, MD; National Cancer Institute/Center for Cancer Research/Vaccine Branch, Bethesda, MD; Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD; NIH, Bethesda, MD; NIH Clinical Center, Bethesda, MD; Biostatistics and Data Management Section, NCI, NIH, Bethesda, MD; Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD; University of Cincinnati Cancer Institute, Cincinnati, OH; Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MDPossible viral oncolysis by members of the Reoviridae and Paramyxoviridae families (an in vitro study).
/in International Publications, Newcastle Disease Virus /von Anastasia O. Sitkovskaya, Elena Yu. Zlatnik, Sergey A. Kolpakov, Elena P. Kolpakova, Inna A. Novikova, Aleksandr B. Sagakyants, Andrey Dashkov, Dmitry O. Kaymakchi, Gapiz M. Chupanov, Patimat M. Gamzatova; Rostov Research Institute of Oncology, Rostov-on-Don, Russian Federation; Rostov Research Institute of Microbiology and Parasitology, Rostov-on-Don, Russian FederationA phase I trial evaluating the safety and efficacy of weekly paclitaxel or cisplatin with electro-hyperthermia in patients with recurrent or persistent epithelial ovarian, fallopian tubal or primary peritoneal carcinoma (KGOG 3030).
/in Hyperthermia, International Publications, Ovarian Cancer /von Kidong Kim, Dong-Hoon Suh, Jae Hong No, Yong Beom Kim, Jae Hoon Kim, Seung Cheol Kim, Woong Ju, Yun Hwan Kim; Korea Cancer Center Hospital, Seoul, South Korea; Department of Obstetrics and Gynecology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-Si, South Korea; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam-Si, South Korea; Yonsei University College of Medicine, Seoul, South Korea; Department of Obstetrics and Gynecology, Ewha Woman's University Mokdong Hospital, Ewha Woman's University School of Medicine, Seoul, South Korea; Ewha Womans University, Seoul, South Korea; Ewha Womans University College of Medicine, Seoul, South KoreaCombination therapy of dendritic cell vaccination plus chemotherapy in pancreatic cancer.
/in Dendritic Cells, International Publications, Pancreatic Cancer /von Maurizio Chiriva-Internati, Leonardo Mirandola, Robert Bresalier, Scott Dahlbeck, Jose A. Figueroa, Diane Duyen Thuy Nguyen; MD Anderson Cancer Center, Department of Lymphoma and Myeloma, and Department of Gastroenterology Hepatology and Nutrition, Houston, TX; Kiromic, Inc., Houston, TX; Department of Gastroenterology Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, TXEffect of targeting CD40 for DC vaccination in pancreatic adenocarcinoma.
/in Dendritic Cells, International Publications, Pancreatic Cancer /von Sai Ping Lau, Nadine van Montfoort, Priscilla Kinderman, Melanie Lukkes, Jasper Dumas, Menno van Nimwegen, Dana Mustafa, Heleen Vroman, Thorbald van Hall, Sjoerd H. van der Burg, Joachim G.J.V. Aerts, Floris Dammeijer, Casper H.J. van Eijck; Erasmus Medical Center, Rotterdam, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Albinusdreef 2, 2333 ZA, Leiden, Netherlands